---
title: "Piper Sandler Keeps Their Buy Rating on Amgen (AMGN)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299896103.md"
description: "Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen today and set a price target of $457.00. According to TipRanks, Amsellem is a 5-star analyst with an average return of 15.4% and a 60.12% success rate. Amsellem covers the Healthcare sector, focusing on stocks such as Amgen, AbbVie, and Teva Pharmaceutical. In addition to Piper Sandler, Amgen also received a Buy from Scotiabank’s Louise Chen in a report issued today. However, on the same day, Truist Financial maintained a Hold rating on Amgen (NASDAQ: AMGN)."
datetime: "2026-09-23T12:25:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299896103.md)
  - [en](https://longbridge.com/en/news/299896103.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299896103.md)
generator: "portal-rs"
---

# Piper Sandler Keeps Their Buy Rating on Amgen (AMGN)

Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen today and set a price target of $457.00.

According to TipRanks, Amsellem is a 5-star analyst with an average return of 15.4% and a 60.12% success rate. Amsellem covers the Healthcare sector, focusing on stocks such as Amgen, AbbVie, and Teva Pharmaceutical.

In addition to Piper Sandler, Amgen also received a Buy from Scotiabank’s Louise Chen in a report issued today. However, on the same day, Truist Financial maintained a Hold rating on Amgen (NASDAQ: AMGN).

### Related Stocks

- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [PIPR.US](https://longbridge.com/en/quote/PIPR.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [TEVA.US](https://longbridge.com/en/quote/TEVA.US.md)
- [BNS.US](https://longbridge.com/en/quote/BNS.US.md)
- [TFC.US](https://longbridge.com/en/quote/TFC.US.md)

## Related News & Research

- [Amgen Inc. $AMGN Shares Acquired by VestGen Advisors LLC](https://longbridge.com/en/news/303720186.md)
- [Amgen Inc. $AMGN Stock Sold by D.A. Davidson & CO.](https://longbridge.com/en/news/303523360.md)
- [AMGEN TO PRESENT NEW DATA ACROSS RARE AND OTHER SERIOUS AUTOIMMUNE DISEASES AT ACR CONVERGENCE 2026 | AMGN Stock News](https://longbridge.com/en/news/303279661.md)
- [FDA warns Amgen over cancer drug promotional video](https://longbridge.com/en/news/303273297.md)
- [AMGN: DeLLphi-305 showed a significant survival benefit for first-line maintenance IMDELLTRA plus IMFINZI](https://longbridge.com/en/news/302970188.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**